SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Yang who wrote (1)3/30/1996 10:49:00 PM
From: RAJU EASON   of 670
 
They had some drugs got FDA approval recently and they are working on several other ones.

PRCY is a development stage pharmaceutical company
engaged in the development of proprietary drugs to address
needs in wound healing, hair growth, bowel disease, and
digestive ulcers. For the 9 months ended 9/30/95, revenues
rose 6% to $3.4M. Net loss fell 54% to $4.3M. Revenues
benefitted from increased interest income. Lower loss
relfects lower research and development expenses related to
the early-stage development of the Company's compounds.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News